Anteris Technologies Global Corp. (AVR) vs Cochlear Limited (COH.AX)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| AVR | COH.AX | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Size band | SMALL | MID |
| Listing | Nasdaq GM | ASX |
| Country | Australia | Australia |
| Theme | medical-devices | medical-devices |
| Price and returns | ||
| Last close | $5.78 | 141.82 AUD |
| Return · 1 week | −6.47% | +1.74% |
| Return · 1 month | −25.32% | −2.28% |
| Return · 3 months | −29.25% | +15.77% |
| Return · year to date | +17.48% | −44.98% |
| Return · 1 year | +10.52% | −50.24% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −47.72% | −52.17% |
| 52-week high | $11.06 | 296.50 AUD |
| 52-week low | $3.30 | 88.74 AUD |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $562.64M | $6.51B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $4.51M | $57.69M |
| Employees | 174 | 5,400 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 62.76× |
| Price to earnings · forward | n/a (negative forward earnings) | 24.75× |
| Price to sales | 254.86× | 3.92× |
| Price to book | 2.27× | 5.28× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 19.33× |
| Enterprise value to revenue | 142.20× | 3.95× |
| PEG ratio | — | 3.08 |
| Earnings per share · trailing | -1.95 | 2.24 |
| Profitability | ||
| Gross margin | 74.98% | 70.69% |
| Operating margin | −3072.05% | 14.33% |
| Profit margin | −4619.27% | 6.27% |
| Return on equity | −74.65% | 7.98% |
| Return on assets | −42.51% | 9.71% |
| Growth | ||
| Revenue growth | +63.30% | +0.80% |
| Balance sheet and payout | ||
| Debt / equity (%) | 1.32 | 12.22 |
| Current ratio | 14.20 | 2.15 |
| Dividend yield | 0.00% | 1.84% |
| Payout ratio | 0.00% | 190.94% |
| Trend and volatility | ||
| RSI · 14 | 24.70 | 58.94 |
| ADX · 14 | 32.19 | 26.37 |
| 50-day average | $7.82 | 136.46 AUD |
| 200-day average | $7.35 | 149.08 AUD |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 5.03% | 2.85% |
The full AVR analysis
Everything this table leaves out for Anteris Technologies Global Corp.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the AVR argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full AVR analysisThe full COH.AX analysis
Everything this table leaves out for Cochlear Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the COH.AX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full COH.AX analysis